Standardizing blood thinner shots for heart patients
Part of Heart & circulation, Injuries & trauma, Pain clinical trials.
This study tests whether a standard way of giving blood thinner shots (LMWH) to people with heart disease in the cardiac care unit improves care. It is for Chinese patients who are awake and can make their own decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in a heart unit (cardiac care unit) for a heart condition
- Your doctor has prescribed a blood thinner shot (LMWH) twice a day
- You are of Chinese ethnicity
- You are able to think clearly and make decisions for yourself
- You are awake and willing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a slightly lower dose of the blood thinner warfarin can lower the risk of stomach or other bleeding, while still protecting against blood clots, in people who have a HeartMate 3 heart pump.
This trial is testing a new way to give blood thinners to people who have been in a serious accident. The goal is to see if adjusting the dose based on your blood levels helps prevent dangerous blood clots.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
This trial tests if a higher dose of a blood thinner (enoxaparin) works better than the standard dose to prevent dangerous blood clots in the legs or lungs after a severe injury. It is for adults in the intensive care unit who are expected to stay more than 48 hours.
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.